Batrash Firas, Shaik Adnan, Rauf Rayaan, Kutmah Mahmoud, Zhang Jun
School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Cancers (Basel). 2024 Mar 10;16(6):1113. doi: 10.3390/cancers16061113.
The intricate interplay between inflammatory processes and the tumor microenvironment (TME) in lung cancer has garnered increasing attention due to its implications for both oncogenesis and therapeutic strategies. In this review, we explore recent advances in understanding the paracrine regulation and immune system pathways within the inflammatory TME of lung cancer. We delve into the molecular mechanisms underpinning oncogenesis, highlighting the role of immune cell populations, cancer-associated fibroblasts, and endothelial cells, as well as their interactions through immune system pathways regulated in a paracrine pattern. Additionally, we discuss emerging immunotherapeutic strategies with a specific focus on the potential of leveraging the inflammatory TME through these pathways to enhance treatment efficacy in lung cancer.
炎症过程与肺癌肿瘤微环境(TME)之间复杂的相互作用因其对肿瘤发生和治疗策略的影响而受到越来越多的关注。在本综述中,我们探讨了在理解肺癌炎症性TME内旁分泌调节和免疫系统途径方面的最新进展。我们深入研究了肿瘤发生的分子机制,强调了免疫细胞群体、癌症相关成纤维细胞和内皮细胞的作用,以及它们通过以旁分泌模式调节的免疫系统途径的相互作用。此外,我们讨论了新兴的免疫治疗策略,特别关注通过这些途径利用炎症性TME来提高肺癌治疗效果的潜力。